IL146417A0 - Ox2 receptor homologs - Google Patents
Ox2 receptor homologsInfo
- Publication number
- IL146417A0 IL146417A0 IL14641700A IL14641700A IL146417A0 IL 146417 A0 IL146417 A0 IL 146417A0 IL 14641700 A IL14641700 A IL 14641700A IL 14641700 A IL14641700 A IL 14641700A IL 146417 A0 IL146417 A0 IL 146417A0
- Authority
- IL
- Israel
- Prior art keywords
- receptor homologs
- homologs
- receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9911123.9A GB9911123D0 (en) | 1999-05-13 | 1999-05-13 | Materials and methods relating to a membrane-bound cell surface protein |
GBGB9925989.7A GB9925989D0 (en) | 1999-11-03 | 1999-11-03 | Mammalian proteins; related reagents and methods |
PCT/US2000/012998 WO2000070045A1 (en) | 1999-05-13 | 2000-05-11 | Ox2 receptor homologs |
Publications (1)
Publication Number | Publication Date |
---|---|
IL146417A0 true IL146417A0 (en) | 2002-07-25 |
Family
ID=26315542
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14641700A IL146417A0 (en) | 1999-05-13 | 2000-05-11 | Ox2 receptor homologs |
Country Status (13)
Country | Link |
---|---|
US (3) | US20060084121A1 (ko) |
EP (3) | EP1177295A1 (ko) |
JP (3) | JP2002543838A (ko) |
KR (5) | KR20110102476A (ko) |
CN (1) | CN1372594A (ko) |
AU (1) | AU5007200A (ko) |
CA (1) | CA2372549A1 (ko) |
HK (1) | HK1044023A1 (ko) |
HU (1) | HUP0203805A3 (ko) |
IL (1) | IL146417A0 (ko) |
MX (1) | MXPA01011519A (ko) |
NZ (1) | NZ515382A (ko) |
WO (1) | WO2000070045A1 (ko) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030166106A1 (en) * | 1997-09-18 | 2003-09-04 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
EP1683865A3 (en) * | 2001-02-02 | 2006-10-25 | Eli Lilly & Company | Mammalian proteins and in particular CD200 |
US7186818B2 (en) | 2001-04-26 | 2007-03-06 | Immunex Corporation | DNA encoding soluble variants of human OX2 receptors |
US7368535B2 (en) * | 2001-05-24 | 2008-05-06 | Trillium Therapeutics Inc. | CD200 receptors |
EP2316485A1 (en) | 2001-10-12 | 2011-05-04 | Schering Corporation | Use of bispecific antibodies to regulate immune responses |
PT1482973E (pt) * | 2002-03-15 | 2009-11-20 | Schering Corp | Métodos de modulação dos receptores cd200 |
AU2003299823A1 (en) * | 2002-12-27 | 2004-07-29 | Schering Corporation | Methods of inducing and maintaining immune tolerance |
WO2004072648A1 (en) * | 2003-02-17 | 2004-08-26 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor ox2r (ox2r) |
MX2009006879A (es) | 2006-12-22 | 2009-07-03 | Schering Corp | Anticuerpos contra el cd200r. |
US8585870B2 (en) * | 2008-03-05 | 2013-11-19 | E I Du Pont De Nemours And Company | Process to C-manufacture acrylonitrile and hydrogen cyanide |
CA3178417A1 (en) | 2020-05-29 | 2021-12-02 | Yu Chen | Anti-cd200r1 antibodies and methods of use thereof |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US169870A (en) * | 1875-11-09 | Improvement in potato-diggers | ||
US244052A (en) * | 1881-07-12 | Railroad-gate | ||
US223991A (en) * | 1880-02-03 | Parent office | ||
US213783A (en) * | 1879-04-01 | Improvement in hot-air engines | ||
GB1319315A (en) | 1969-06-19 | 1973-06-06 | Citizen Watch Co Ltd | Calendar timepiece |
US3940475A (en) | 1970-06-11 | 1976-02-24 | Biological Developments, Inc. | Radioimmune method of assaying quantitatively for a hapten |
NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
US3817837A (en) | 1971-05-14 | 1974-06-18 | Syva Corp | Enzyme amplification assay |
US3939350A (en) | 1974-04-29 | 1976-02-17 | Board Of Trustees Of The Leland Stanford Junior University | Fluorescent immunoassay employing total reflection for activation |
US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
US4277437A (en) | 1978-04-05 | 1981-07-07 | Syva Company | Kit for carrying out chemically induced fluorescence immunoassay |
US4366241A (en) | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
US4659678A (en) | 1982-09-29 | 1987-04-21 | Serono Diagnostics Limited | Immunoassay of antigens |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US4859609A (en) | 1986-04-30 | 1989-08-22 | Genentech, Inc. | Novel receptors for efficient determination of ligands and their antagonists or agonists |
US7339033B2 (en) * | 1998-06-26 | 2008-03-04 | Genentech, Inc. | Pro1481 |
CA2339301A1 (en) * | 1998-07-30 | 2000-02-10 | Human Genome Sciences, Inc. | Hdpbo81 nucleic acids and polypeptides |
AU6802801A (en) * | 2000-03-01 | 2001-09-24 | Genentech Inc | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
PT1482973E (pt) * | 2002-03-15 | 2009-11-20 | Schering Corp | Métodos de modulação dos receptores cd200 |
AU2003299823A1 (en) * | 2002-12-27 | 2004-07-29 | Schering Corporation | Methods of inducing and maintaining immune tolerance |
US20070244052A1 (en) * | 2003-12-19 | 2007-10-18 | Schering Corporation | Methods for Identifying Agonists or Antagonists of CD200R Signaling Molecules and Methods of Using the Same |
EP1718333A2 (en) * | 2004-02-02 | 2006-11-08 | Schering Corporation | Methods of modulating cd200 and cd200r |
MX2009006879A (es) * | 2006-12-22 | 2009-07-03 | Schering Corp | Anticuerpos contra el cd200r. |
US11068393B2 (en) | 2019-10-17 | 2021-07-20 | Microsoft Technology Licensing, Llc | Enhanced concurrency garbage collection stack scanning |
-
2000
- 2000-05-11 EP EP00932337A patent/EP1177295A1/en not_active Withdrawn
- 2000-05-11 JP JP2000618451A patent/JP2002543838A/ja active Pending
- 2000-05-11 MX MXPA01011519A patent/MXPA01011519A/es active IP Right Grant
- 2000-05-11 NZ NZ515382A patent/NZ515382A/xx not_active IP Right Cessation
- 2000-05-11 KR KR1020117017533A patent/KR20110102476A/ko not_active Application Discontinuation
- 2000-05-11 KR KR1020097023546A patent/KR101018176B1/ko not_active IP Right Cessation
- 2000-05-11 WO PCT/US2000/012998 patent/WO2000070045A1/en active Application Filing
- 2000-05-11 CN CN00810289A patent/CN1372594A/zh active Pending
- 2000-05-11 IL IL14641700A patent/IL146417A0/xx unknown
- 2000-05-11 HU HU0203805A patent/HUP0203805A3/hu unknown
- 2000-05-11 KR KR1020097000826A patent/KR101018134B1/ko not_active IP Right Cessation
- 2000-05-11 KR KR1020107021793A patent/KR20100123890A/ko active IP Right Grant
- 2000-05-11 AU AU50072/00A patent/AU5007200A/en not_active Abandoned
- 2000-05-11 EP EP10182832A patent/EP2336321A1/en not_active Withdrawn
- 2000-05-11 EP EP10182850A patent/EP2341143A1/en not_active Withdrawn
- 2000-05-11 KR KR1020017014308A patent/KR101005124B1/ko not_active IP Right Cessation
- 2000-05-11 CA CA002372549A patent/CA2372549A1/en not_active Abandoned
-
2002
- 2002-07-30 HK HK02105582.1A patent/HK1044023A1/zh unknown
-
2005
- 2005-09-22 US US11/233,798 patent/US20060084121A1/en not_active Abandoned
-
2007
- 2007-07-09 JP JP2007180348A patent/JP2007319163A/ja active Pending
-
2008
- 2008-08-21 US US12/196,188 patent/US20090012270A1/en not_active Abandoned
-
2011
- 2011-12-28 JP JP2011289718A patent/JP2012072186A/ja not_active Withdrawn
-
2012
- 2012-03-16 US US13/422,436 patent/US20120231003A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
NZ515382A (en) | 2004-03-26 |
EP2341143A1 (en) | 2011-07-06 |
JP2007319163A (ja) | 2007-12-13 |
WO2000070045A1 (en) | 2000-11-23 |
KR101018176B1 (ko) | 2011-02-28 |
KR20090133133A (ko) | 2009-12-31 |
US20120231003A1 (en) | 2012-09-13 |
US20060084121A1 (en) | 2006-04-20 |
MXPA01011519A (es) | 2003-08-20 |
KR20020047036A (ko) | 2002-06-21 |
HUP0203805A2 (hu) | 2003-03-28 |
KR20110102476A (ko) | 2011-09-16 |
KR20090025341A (ko) | 2009-03-10 |
US20090012270A1 (en) | 2009-01-08 |
KR101005124B1 (ko) | 2011-01-04 |
KR20100123890A (ko) | 2010-11-25 |
CN1372594A (zh) | 2002-10-02 |
HUP0203805A3 (en) | 2012-09-28 |
CA2372549A1 (en) | 2000-11-23 |
EP2336321A1 (en) | 2011-06-22 |
KR101018134B1 (ko) | 2011-02-25 |
EP1177295A1 (en) | 2002-02-06 |
JP2002543838A (ja) | 2002-12-24 |
HK1044023A1 (zh) | 2002-10-04 |
JP2012072186A (ja) | 2012-04-12 |
AU5007200A (en) | 2000-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1189609A4 (en) | CXCR-4 RECEPTOR ANTAGONISTS AND THROMBOPOIETIN MIMETIKA | |
GB0015176D0 (en) | Early entry | |
GB0016917D0 (en) | Early entry | |
EP1151955A4 (en) | ELEVATOR DEVICE | |
IL144875A0 (en) | Receptor assay | |
IL146151A0 (en) | Human-g-protein receptor | |
HUP0203805A3 (en) | Ox2 receptor homologs | |
EG24025A (en) | Vitronectin receptor antagonist | |
IL154654A0 (en) | Osteoclast-associated receptor | |
EP1084142A4 (en) | GPR35A RECEIVER | |
GB0025045D0 (en) | Early Entry | |
AU1252102A (en) | Receptor | |
GB0000474D0 (en) | Receptor | |
EP1223946A4 (en) | HUMAN NEUROPEPTIDE RECEPTOR | |
IL154317A0 (en) | Imidazoline receptor homologs | |
GB9927215D0 (en) | Hormone receptor expression | |
GB0007274D0 (en) | Lavatories | |
GB0023554D0 (en) | Early entry | |
GB0031096D0 (en) | Receptor | |
GB0111959D0 (en) | Receptor | |
GB0125183D0 (en) | Receptor | |
GB0114929D0 (en) | Receptor | |
GB0110662D0 (en) | Receptor | |
GB0107914D0 (en) | 7tm receptor hlwar77 | |
CA85884S (en) | Hand-rail union |